Development of a multimodal model integrating #ctDNA dynamics, normalized #bTMB, and first #RECIST response to predict durable benefit in #NSCLC patients treated with #ICIs, demonstrating high accuracy and robust validation.
#CoverPage in #STTT: doi.org/10.1038/s413...